Third-generation cephalosporin and carbapenem resistance in Streptococcus mitis/oralis. Results from a nationwide registry in the Netherlands

Dutch National AMR Surveillance Study Group

doi:https://doi.org/10.1016/j.cmi.2018.11.021

Third-generation cephalosporin and carbapenem resistance in Streptococcus mitis/oralis. Results from a nationwide registry in the Netherlands

DSpace/Manakin Repository

Third-generation cephalosporin and carbapenem resistance in Streptococcus mitis/oralis. Results from a nationwide registry in the Netherlands

Dutch National AMR Surveillance Study Group

(2019) Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, volume 25, issue 4, pp. 518 - 520

(Letter)

Download/Full Text

The full text of this publication is not available.

Version on publisher website for UU-students and staff

Version on publisher website

Keywords: Anti-Bacterial Agents/pharmacology, Carbapenems/pharmacology, Cephalosporins/pharmacology, Humans, Microbial Sensitivity Tests, Netherlands/epidemiology, Prevalence, Registries/statistics & numerical data, Streptococcal Infections/epidemiology, Streptococcus mitis/drug effects, Streptococcus oralis/drug effects, beta-Lactam Resistance, Letter

DOI: https://doi.org/10.1016/j.cmi.2018.11.021

ISSN: 1198-743X

Publisher: Elsevier

(Peer reviewed)